A phase 4 randomized, active-comparator controlled clinical trial to study the safety of sugammadex (MK-8616) for the reversal of neuromuscular blockade induced by either rocuronlum bromide or vecuronium in American Society of Anesthesiologists (ASA) class 3 or 4 subjects. MK-8616-145-00,
Role: Investigator,
Merck, Sharp & Dohme Corp.,
(01/2019 - 01/2020)
Status: Completed
Air purge air detection and removal system; post-approval multi-center clinical protocol,
Role: Investigator,
Anesthesia Safety Products (ASP), LLC,
(10/2017 - 10/2018)
Status: Completed
Esmolol or nitroglycerin infusion for blood pressure control prior to CPB in cardiac surgery: a randomized, controlled trial,
Role: Investigator,
Baxter Healthcare Corporation,
(07/2013 - 07/2014)
Status: Completed
Internal
Median versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison,
Role: Investigator,
LLU Dept. of Anesthesiology,
(06/2024)
Status: Approved
Continuous intraoperative glucose monitoring: A pilot study,
Role: Investigator,
LLU Dept. of Anesthesiology,
(03/2024)
Status: Approved
Point-of-care ultrasound evaluation in the post-anesthesia unit -A collaborative observational study between UCLA and Loma Linda University Medical centers,
Role: Investigator,
LLU Dept. of Anesthesiology,
(03/2021 - 03/2022)
Status: Completed
Stroke volume variations from radial artery during surgery in patients with end stage renal disease as a marker of fluid responsiveness,
Role: PI,
LLU Dept. of Anesthesiology,
(08/2017 - 08/2018)
Status: Completed
Non-Profit Organization
Multi-site anesthesia randomized controlled study of end tidal control (Et Control) compared to conventional anesthesia results (Master-Anesthesia Trial),
Role: Investigator,
General Electric Company,
(02/2018 - 02/2019)
Status: Completed